Haemonetics Corp. reported its third-quarter results, yesterday, earning $18.3 million, or 71 cents per share in revenue.

It will buy all outstanding common shares of Global Med Technologies Inc. for $1.22 each and its preferred stock at about $1,694 per share. It expects to save more than $100 million at the end of its fiscal year. It's a sizable investment and Haemonetics' shares sank by nearly 5 percent, or $2.61, to $54.

The company provides blood collection and separation technologies, surgical blood salvage systems and blood management diagnostic products. It also markets information technology platforms and consulting services, for the management of blood supply chains.

Plasma disposables revenue rose by 10 % in the 3rd quarter. Platelet disposables revenue climbed to $40 million, and software solution's revenue was up by 9 %. Red cell disposables' revenue fell by 8 % to $12 million.